Hanu Tyagi
Contact
Education:
-
Bachelor of Technology 2008Mechanical Engineering, National Institute of Technology, Warangal (India)
-
Post-Graduate Programme in Management 2013Management, Indian School of Business, Hyderabad (India)
-
Ph.D. (Ongoing)Supply Chain and Operations, Carlson School of Management, University of Minnesota - Twin Cities
Expertise:
-
New product development
-
Innovation
-
Shortages
-
Supply chain transparency
Biography
I am a fourth-year Ph.D. candidate in the Supply Chain and Operations department at the Carlson School of Management, University of Minnesota. I am interested in studying how operational decisions affect the development and distribution of pharmaceutical drugs. My questions explore themes such as supply chain transparency, innovation, new product development, and shortages. I use a mix of empirical and experimental research methodologies and theory-driven frameworks to answer my research questions.
- Under the drug development stream, I explore
- How expedited new product development leads to issues in drug quality?
- How transparency in new product development impacts drug innovation?
- Under the drug distribution stream, I examine
- How transparency in the supply chain impacts shortages?
- How does quality failure spill over?
- How inventory transparency affects panic buying?
Before joining the Ph.D. program, I worked as a Research Associate at the Indian School of Business, Hyderabad (India) with Professor Sarang Deo. Before entering academia, I worked as a management consultant at EY-Parthenon (Dubai, UAE) and ZS Associates (Pune, India). I also worked in the management trainee program at Ranbaxy Labs. Ltd (Gurgaon, India). I have a Post-Graduate Programme in Management from the Indian School of Business, Hyderabad (India), and a Bachelor of Technology from the National Institute of Technology, Warangal (India)
On the personal front, I am a traveler, a hiking/trekking enthusiast, and an open-water scuba diver. I am also an avid music lover who is learning Hindustani classical singing.
Selected Works & Activities
-
Journal ArticlesDeo, S., H. Tyagi, C. Chatterjee, H. Molakapuri. 2019. Did India's price control policy for coronary stents create unintended consequences? Social Science & Medicine 246, 112737
-
Journal ArticlesH. Tyagi, M. Sabharwal, N. Dixit, A. Pal, S. Deo. 2020. Leveraging providers' preferences to customize instructional content: A retrospective analysis of a mobile phone-based intervention. JMIR mHealth and uHealth 8 (3), e15998
-
Conference ProceedingsV Heitlage, JF Farley, R Shah, H Tyagi, D Stenehjem. 2022. EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health 25 (7), S460
-
OtherAC Powell, H Tyagi, JK Ludher. 2018. Digitising Indian healthcare records. Healthcare cover story, ISBInsight